Abstract:Prokaryotic CRISPR-Cas immunity is subverted by anti-CRISPRs (Acrs), which inhibit Cas protein activities when expressed during the phage lytic cycle or from resident prophages or plasmids1. Acrs often bind to specific cognate Cas proteins, and hence inhibition is typically limited to a single CRISPR-Cas subtype2. Furthermore, although acr genes are frequently organized together in phage-associated gene clusters3, how such inhibitors initially evolve has remained unclear. Here we investigated the Acr content and inhibition specificity of diverse Listeria isolates, which naturally harbour four CRISPR-Cas systems (types I-B, II-A, II-C and VI-A). We observed widespread antagonism of CRISPR, which we traced to 11 previously unknown and 4 known acr gene families encoded by endogenous mobile elements. Among these were two Acrs that possess sequence homology to type I-B Cas proteins, one of which assembles into a defective interference complex. Surprisingly, an additional type I-B Cas homologue did not affect type I immunity, but instead inhibited the RNA-targeting type VI CRISPR system by means of CRISPR RNA (crRNA) degradation. By probing viral sequence databases, we detected abundant orphan cas genes located within putative anti-defence gene clusters. Among them, we verified the activity of a particularly broad-spectrum cas3 homologue that inhibits type I-B, II-A and VI-A CRISPR immunity. Our observations provide direct evidence of Acr evolution by cas gene co-option, and new genes with potential for broad-spectrum control of genome editing technologies.

Phage anti-CBASS and anti-Pycsar nucleases subvert bacterial immunity

Phage anti-CBASS protein simultaneously sequesters cyclic trinucleotides and dinucleotides

A large-scale type I CBASS antiphage screen identifies the phage prohead protease as a key determinant of immune activation and evasion

Convergent mutations in phage virion assembly proteins enable evasion of Type I CBASS immunity

A widespread phage-encoded kinase enables evasion of multiple host antiphage defence systems

Phage CRISPR-like regulatory RNAs silence bacterial adaptive and innate immunity

Prophage integration into CRISPR loci enables evasion of antiviral immunity in Streptococcus pyogenes

Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity

Reversible conjugation of a CBASS nucleotide cyclase regulates bacterial immune response to phage infection

The arms race between bacteria CBASS and bacteriophages

Bacteriophages suppress CRISPR–Cas immunity using RNA-based anti-CRISPRs

Diverse viral cas genes antagonize CRISPR immunity

Cyclic CMP and cyclic UMP mediate bacterial immunity against phages

Phage defence system CBASS is regulated by a prokaryotic E2 enzyme that imitates the ubiquitin pathway

A bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases

Structure-guided discovery of anti-CRISPR and anti-phage defense proteins

Single phage proteins sequester TIR- and cGAS-generated signaling molecules

Animal and bacterial viruses share conserved mechanisms of immune evasion

Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer

An enterococcal phage protein broadly inhibits type IV restriction enzymes involved in antiphage defense

The novel anti-CRISPR AcrIIA22 relieves DNA torsion in target plasmids and impairs SpyCas9 activity